Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Chronic diseases, particularly obesity and type 2 diabetes, represent a growing global health challenge, necessitating innovative therapeutic approaches. Among the most promising advancements is Mazdutide, an advanced peptide therapy that heralds a new era in chronic disease management. Its unique design as a glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR) dual agonist distinguishes it from existing treatments, offering a multi-faceted attack on metabolic dysregulation.
As an oxyntomodulin analogue, Mazdutide leverages the benefits of both GLP-1 and glucagon pathways. The GLP-1 component promotes insulin secretion, lowers blood glucose, and reduces appetite, while the glucagon component increases energy expenditure and improves hepatic fat metabolism. This synergistic action not only leads to robust weight loss but also contributes to significant improvements in various cardiometabolic indicators. The ability of Mazdutide to address multiple facets of metabolic syndrome makes it an incredibly versatile and potent tool in the fight against chronic conditions.
Clinical studies have consistently demonstrated Mazdutide’s efficacy across a spectrum of metabolic parameters. Patients on Mazdutide have shown impressive reductions in body weight, waist circumference, blood pressure, blood lipids, and liver fat content. These comprehensive benefits underscore its potential to significantly reduce the burden of obesity-related comorbidities. The favorable safety profile, characterized by mild and transient gastrointestinal side effects, further reinforces its suitability for long-term chronic disease management. NINGBO INNO PHARMCHEM CO.,LTD. is a leading Mazdutide supplier, ensuring researchers and pharmaceutical developers have access to high-quality materials for their projects.
The development of advanced peptide therapies like Mazdutide is critical for meeting the unmet clinical needs in chronic disease management. Its once-weekly administration offers convenience, potentially improving patient adherence to treatment regimens. As a key player in providing raw materials for pharmaceutical innovation, NINGBO INNO PHARMCHEM CO.,LTD. supports the widespread adoption of such groundbreaking solutions. For those looking to purchase Mazdutide or inquire about its specifications, NINGBO INNO PHARMCHEM CO.,LTD. offers a reliable source, paving the way for further research into the broad therapeutic applications of this advanced peptide therapy beyond just effective obesity treatment.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
